SCHEMBL6557782

SCHEMBL6557782

CCNCC(=O)CNS(=O)(=O)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 11/20 0.64
▸ MMP1 P03956 7/20 0.64
▸ ADAMTS4 O75173 5/20 0.64
▸ MMP13 P45452 5/20 0.64
▸ MMP14 P50281 4/20 0.64
▸ ADAMTS5 Q9UNA0 4/20 0.64
▸ MEP1B Q16820 1/20 0.64
▸ CTSK P43235 2/20 0.53
▸ CTSS P25774 1/20 0.53
▸ CA2 P00918 6/20 0.51
▸ CA9 Q16790 6/20 0.51
▸ CA12 O43570 5/20 0.51
▸ CA1 P00915 5/20 0.51
▸ MMP9 P14780 3/20 0.49
▸ GAA P10253 1/20 0.47
▸ MMP12 P39900 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ STAT3 P40763 1/20 0.46
▸ HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6557790 0.87 MMP1 (0.50) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL8048075 0.83 MMP2 (0.65) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL6557780 0.82 MMP2 (0.61) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL7247467 0.82 MMP2 (0.72) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL7163404 0.81 MMP2 (0.62) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL5899447 0.78 MMP2 (0.70) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL5445424 0.77 MMP2 (0.61) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL5445420 0.77 MMP2 (0.61) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL7168984 0.77 KAT6A (0.58) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL14565746 0.76 MMP2 (0.56) MMP2MMP1ADAMTS4MMP13MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 — — EP claimed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 — — WO claimed
Send feedback